Koers Edwards Lifesciences Corporation
Aandelen
EW
US28176E1082
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
85,09 USD | -0,87% | +0,50% | +11,59% |
Omzet 2024 * | 6,56 mld. 6,1 mld. | Omzet 2025 * | 7,2 mld. 6,7 mld. | Marktkapitalisatie | 51,73 mld. 48,12 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,62 mld. 1,51 mld. | Nettowinst (verlies) 2025 * | 1,86 mld. 1,73 mld. | EV/omzet 2024 * | 7,63 x |
Nettoliquiditeiten 2024 * | 1,68 mld. 1,56 mld. | Nettoliquiditeiten 2025 * | 2,84 mld. 2,64 mld. | EV/omzet 2025 * | 6,79 x |
K/w-verhouding 2024 * |
32,3
x | K/w-verhouding 2025 * |
27,9
x | Werknemers | 19.800 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,6% |
Recentste transcriptie over Edwards Lifesciences Corporation
1 dag | -0,87% | ||
1 week | +0,50% | ||
Lopende maand | +0,50% | ||
1 maand | -8,21% | ||
3 maanden | -1,75% | ||
6 maanden | +27,90% | ||
Lopend jaar | +11,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-01-15 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01-01-14 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05-07-16 |
Chairman | 67 | 13-11-14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.46% | 0 M€ | +1,60% | - | |
2.34% | 0 M€ | +5,61% | - | |
2.13% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
08-05-24 | 85,09 | -0,87% | 1 718 830 |
07-05-24 | 85,84 | +0,88% | 1 836 563 |
06-05-24 | 85,09 | -0,19% | 2 449 673 |
03-05-24 | 85,25 | +0,22% | 2 327 197 |
02-05-24 | 85,06 | +0,90% | 1 942 855 |
uitgestelde koers Nyse, 08 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,59% | 51,73 mld. | |
+8,07% | 219 mld. | |
+7,87% | 184 mld. | |
+12,75% | 138 mld. | |
-1,37% | 62,54 mld. | |
+4,88% | 52,22 mld. | |
+2,71% | 41,4 mld. | |
+4,90% | 37,17 mld. | |
+23,75% | 31,76 mld. | |
+15,48% | 24,18 mld. |